Vitreous Disease in Retinoblastoma: Clinical Findings and Treatment

Overview

Journal Adv Ophthalmol Optom

Date 2017 Oct 17

PMID 29034355

Citations 3

Authors

Jasmine H Francis

Larissa A Habib

David H Abramson

Affiliations

Soon will be listed here.

Citing Articles

Intravitreal chemotherapy-induced cataract in retinoblastoma: challenges and outcome.

Warkad V, Tripathy D BMJ Case Rep. 2022; 15(12).

PMID: 36535729 PMC: 9764654. DOI: 10.1136/bcr-2022-250617.

ERG and OCT abnormalities in retinoblastoma after melphalan intravitreous injection.

Albuquerque M, Moreto R, Bergamo M, Correa Z, Jorge R Arq Bras Oftalmol. 2022; 87(1):0037.

PMID: 35857974 PMC: 11606518. DOI: 10.5935/0004-2749.2021-0037.

Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.

Cobbs L, Francis J, Dunkel I, Gobin Y, Brodie S, Abramson D Pediatr Blood Cancer. 2020; 68(5):e28845.

PMID: 33355996 PMC: 9316827. DOI: 10.1002/pbc.28845.

References

Munier F . Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013. Ophthalmic Genet. 2014; 35(4):193-207. PMC: 4245997. DOI: 10.3109/13816810.2014.973045. View

Chevez-Barrios P, Chintagumpala M, Mieler W, Paysse E, Boniuk M, Kozinetz C . Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir. J Clin Oncol. 2005; 23(31):7927-35. DOI: 10.1200/JCO.2004.00.1883. View

Munier F, Gaillard M, Balmer A, Beck-Popovic M . Intravitreal chemotherapy for vitreous seeding in retinoblastoma: Recent advances and perspectives. Saudi J Ophthalmol. 2013; 27(3):147-50. PMC: 3770220. DOI: 10.1016/j.sjopt.2013.06.003. View

Francis J, Schaiquevich P, Buitrago E, Del Sole M, Zapata G, Croxatto J . Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study. Ophthalmology. 2014; 121(9):1810-7. DOI: 10.1016/j.ophtha.2014.03.028. View

Ghassemi F, Shields C, Ghadimi H, Khodabandeh A, Roohipoor R . Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma. JAMA Ophthalmol. 2014; 132(8):936-41. DOI: 10.1001/jamaophthalmol.2014.414. View

Munier F, Gaillard M, Balmer A, Soliman S, Podilsky G, Moulin A . Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012; 96(8):1078-83. DOI: 10.1136/bjophthalmol-2011-301450. View

Francis J, Brodie S, Marr B, Zabor E, Mondesire-Crump I, Abramson D . Efficacy and Toxicity of Intravitreous Chemotherapy for Retinoblastoma: Four-Year Experience. Ophthalmology. 2017; 124(4):488-495. PMC: 5441308. DOI: 10.1016/j.ophtha.2016.12.015. View

ERICSON L, ROSENGREN B . Present therapeutic resources in retinoblastoma. Acta Ophthalmol (Copenh). 1961; 39:569-76. DOI: 10.1111/j.1755-3768.1961.tb00269.x. View

Francis J, Xu X, Gobin Y, Marr B, Brodie S, Abramson D . Death by water: precautionary water submersion for intravitreal injection of retinoblastoma eyes. Open Ophthalmol J. 2014; 8:7-11. PMC: 4062941. DOI: 10.2174/1874364101408010007. View

10.

Francis J, Mondesire-Crump I, Marr B, Brodie S, Abramson D . Cytopathological Evaluation of Ocular Surface and Needle Washings Following Intravitreal Melphalan Injections for Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2016; 53(2):96-98. PMC: 5457357. DOI: 10.3928/01913913-20160311-01. View

11.

Francis J, Marr B, Brodie S, Gobin Y, Abramson D . Tethered vitreous seeds following intravitreal melphalan for retinoblastoma. JAMA Ophthalmol. 2014; 132(8):1024-5. DOI: 10.1001/jamaophthalmol.2014.436. View

12.

Kaneko A, Suzuki S . Eye-preservation treatment of retinoblastoma with vitreous seeding. Jpn J Clin Oncol. 2004; 33(12):601-7. View

13.

Ghassemi F, Amoli F . Pathological findings in enucleated eyes after intravitreal melphalan injection. Int Ophthalmol. 2013; 34(3):533-40. DOI: 10.1007/s10792-013-9851-2. View

14.

Abramson D, Fabius A, Francis J, Marr B, Dunkel I, Brodie S . Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma. Ophthalmic Genet. 2017; 38(1):16-21. PMC: 5475401. DOI: 10.1080/13816810.2016.1244695. View

15.

Karl M, Francis J, Iyer S, Marr B, Abramson D . Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding. J Pediatr Ophthalmol Strabismus. 2017; 54(3):185-190. PMC: 5473509. DOI: 10.3928/01913913-20161116-01. View

16.

Smith S, Smith B, Mohney B . Ocular side effects following intravitreal injection therapy for retinoblastoma: a systematic review. Br J Ophthalmol. 2013; 98(3):292-7. DOI: 10.1136/bjophthalmol-2013-303885. View

17.

Munier F, Soliman S, Moulin A, Gaillard M, Balmer A, Beck-Popovic M . Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track. Br J Ophthalmol. 2012; 96(8):1084-7. DOI: 10.1136/bjophthalmol-2011-301016. View

18.

Ueda M, Tanabe J, Inomata M, Kaneko A, Kimura T . [Study on conservative treatment of retinoblastoma--effect of intravitreal injection of melphalan on the rabbit retina]. Nippon Ganka Gakkai Zasshi. 1995; 99(11):1230-5. View

19.

Francis J, Marr B, Brodie S, Abramson D . Anterior Ocular Toxicity of Intravitreous Melphalan for Retinoblastoma. JAMA Ophthalmol. 2015; 133(12):1459-63. PMC: 4979541. DOI: 10.1001/jamaophthalmol.2015.3119. View

20.

Shimoda Y, Hamano R, Ishihara K, Shimoda N, Hagimura N, Akiyama H . Effects of intraocular irrigation with melphalan on rabbit retinas during vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2007; 246(4):501-8. DOI: 10.1007/s00417-007-0685-3. View